Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO
BERKELEY HEIGHTS, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;
Globe Newswire30-01-2023, 21:17
Descartes’ Study Reveals 65% of Companies Plan to Accelerate Supply Chain and Logistics Innovation Investment 30-01-2023, 18:45